3 examples of why you need to question share market forecasts

Forecasts are part of the reason why so many investors lost money in Fortescue Metals Group Limited (ASX:FMG) over the last 12 months.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Morgan Housel, my Foolish colleague from The Motley Fool US, wrote some time ago that "a stock's future returns will equal its dividend yield, plus its earnings growth, plus or minus changes in valuations (earnings multiples). That's really all there is to it."

Most investors that follow the Foolish methodology would agree with him, however his theory that "dividends and earnings growth for many companies can be reasonably projected" has been tested in the ASX market by a couple of prominent companies over the last 12 months.

Share market Returns

As Morgan wrote, there are three basic variables that need to be taken into account when determining the value of a company; its earnings growth, its dividend, and the price to earnings (PE) ratio that it trades at.

Now, let's be clear, it's very difficult to know the PE ratio that a company will trade at as it "reflect[s] people's feelings about the future, swinging between optimism and fear. And there's just no way to know what people are going to think about the future in the future." So let's assume we can't forecast the price to earnings ratio, what about earnings and dividends?

Earnings Forecasts

I'm sure there are thousands of investors out there that make investing decisions based solely on the forecasts of analysts. However, I believe we all need to take a step back and consider the risks before taking their forecasts as gospel.

Example 1: Metcash Limited (ASX: MTS)

Metcash was once considered a reliable dividend stock and predicted by almost every analyst to continue being that way for the foreseeable future. Just 12 months ago analysts expected a total dividend payout 17.1 cents this financial year, representing a 15% yield based on today's price of $1.17, and even six months ago they were expecting 12.5 cents. Today we know that Metcash will not pay a final dividend this year or a dividend at all next financial year as the company attempts to turn-around its struggling operations.

Example 2: Fortescue Metals Group Limited (ASX: FMG)

2014 was a good year for Fortescue. A high iron ore price and swift payment of outstanding debt saw analysts in April 2014 (14 months ago) predict a 2015 financial-year earnings per share forecast of 75 cents and dividend per share forecast of 33 cents. The current consensus forecast? Earnings per share of 9.9 cents and dividend per share of 5.7 cents! Their $80 per tonne iron ore forecast was wrong, however there were very few that saw the plunge to $45 per tonne coming.

Example 3: Woolworths Limited (ASX: WOW)

Woolies is perhaps the highest-profile victim of analysts getting it wrong lately. When the share price was sitting around $38 in mid-2014, analysts forecast a handy 10% increase in earnings per share to around 216 cents in 2015, and similar growth in dividend to 150 cents per share. The well-publicised growth issues have resulted in a 27% fall in the share price to just $27 and earnings per share are now expected to be flat at 195 cents, potentially falling to 190 cents in 2016.

The Lesson?

Charlie Munger, Warren Buffett's investing partner, put it best: "You don't have to be brilliant, only a little bit wiser than the other guys, on average, for a long, long time."

Take your time to assess the risks that a company faces and if that risk is too great then simply don't invest. The worst that can happen is that you'll miss out on some gains, but you'll pass the sleep-at-night test that can cause you trouble when investing in a company you don't really believe in. In addition, there are typically hundreds of companies that perform well over any time period, so hopefully you're investing in a better company instead.

Motley Fool contributor Andrew Mudie owns shares of Fortescue Metals Group Limited. You can find Andrew on Twitter @andrewmudie The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »